Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | Breast Cancer Clinical Trials in Maryland | 900 Studies

Clinical Trials Breast CancerMaryland

Breast Cancer Clinical Trials in Maryland

Find 900 clinical trials for breast cancer near Maryland. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Maryland

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 341-360 of 900 trials

CompletedOlaparib in Combination With Carboplatin for Refractory or Recurrent Women s CancersBackground: \- Olaparib is an experimental anti-cancer drug that is part of a class of drugs called PARP inhibitors.NCT01237067·Bethesda, Maryland

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedTamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast CancerThis randomized phase III trial studies tamoxifen citrate or letrozole together with bevacizumab to see how well it works compared with tamoxifen citrate or letrozole alone in…NCT00601900·Mobile, Alabama and 521 others

Active not recruitingMeasuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair VariationsThis phase II trial studies if talazoparib works in patients with cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the…NCT04550494·Gainesville, Florida and 3 others

CompletedStudy of 2 Ribociclib Doses in Combination With Aromatase Inhibitors in Women With HR+, HER2- Advanced Breast CancerThe purpose of the study was to evaluate the safety and efficacy of a reduced ribociclib starting dose of 400 mg in combination with a non-steroidal aromatase inhibitor (NSAI)…NCT03822468·Mobile, Alabama and 88 others

CompletedEvaluating Coaches of Older Adults for Cancer Care and Health BehaviorsThe overall goal of the COACH study is to conduct a comparative effectiveness trial to assess the effectiveness of trained, participant-designated health coaches versus…NCT01613430·Baltimore, Maryland

CompletedA Study of SU11248 In Patients With Metastatic Breast Cancer Who Have Failed Selected Other Therapies.Assessment of safety and efficacy of SU11248 in patients with metastatic breast cancer who have failed selected other therapies.NCT00078000·Greenbrae, California and 9 others

CompletedA Phase 3 Randomized, Placebo-controlled Trial of Carboplatin and Paclitaxel With or Without Veliparib (ABT-888) in HER2-negative Metastatic or Locally Advanced Unresectable BRCA-associated Breast CancerThe primary objective of the study is to assess the progression-free survival (PFS) of veliparib in combination with carboplatin and paclitaxel (C/P) compared to placebo plus C/P…NCT02163694·Gilbert, Arizona and 218 others

RecruitingConventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton TherapyThe purpose of this research study is to learn more about the effects of using proton radiation therapy delivered over a shorter course of treatment (3 weeks) compared with a…NCT05856773·Scottsdale, Arizona and 8 others

CompletedAnalysis of Surgery in Patients Presenting With Stage IV Breast CancerThe purpose of this study is to study patients presenting with stage IV breast cancer.NCT00941759·Birmingham, Alabama and 19 others

CompletedOral Drug Study In Women With Refractory Metastatic Breast Cancer After First-line or Second-line Herceptin.The purpose of this study is to determine the efficacy of an oral investigational drug for the treatment of metastatic breast cancer tumors that are known to overexpress HER2/neu.NCT00051103·Chula Vista, California and 29 others

CompletedRandomized Phase III Study Of Exemestane (Aromasin) For 5 Years Versus Tamoxifen for 2.5 to 3 Years Followed By ExemestaneTo compare the effects of exemestane for 5 years versus tamoxifen and exemestane given sequentially over 5 years in the adjuvant treatment of postmenopausal women with early…NCT00036270·Bessemer, Alabama and 178 others

CompletedDocetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast CancerRATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of breast cancer cells, either by killing the cells or by stopping them from dividing.NCT01547741·Anchorage, Alaska and 914 others

RecruitingA Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast CancerThe efficacy and safety of zanidatamab in combination with physician's choice of chemotherapy compared with trastuzumab in combination with physician's choice of chemotherapy will…NCT06435429·Phoenix, Arizona and 165 others

CompletedPrognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I or Stage IIA Breast CancerRATIONALE: Biopsy of sentinel lymph nodes and bone marrow may improve the ability to detect and determine the extent of cancer.NCT00003854·Birmingham, Alabama and 115 others

Active not recruitingNBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 TherapyThe 1100 study is an open-label, Phase I, dose escalation and expansion prospective clinical study to assess the safety of intratumoral injection of NBTXR3 activated by…NCT03589339·San Francisco, California and 12 others

Active not recruitingA Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05)Patients with HER2-positive primary breast cancer (BC) who do not achieve complete response after appropriate neoadjuvant therapy are at higher risk of disease recurrence.NCT04622319·Anaheim, California and 481 others

TerminatedA Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast CancerThis is an adaptive Phase 2, open-label, randomized, multi-center study evaluating up to 2 regimens of PCS6422 with capecitabine (Cap) vs. standard dose of Cap alone in patients…NCT06568692·Los Angeles, California and 11 others

CompletedTykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast CancerThis study was designed to evaluate and compare the safety and efficacy of an oral dual tyrosine kinase inhibitor, lapatinib, versus placebo in women with early-stage…NCT00374322·Tuscaloosa, Alabama and 438 others

CompletedSafety and Efficacy of SGN-LIV1A Plus Pembrolizumab for Patients With Locally-Advanced or Metastatic Triple-Negative Breast CancerThis trial studies ladiratuzumab vedotin (LV) with pembrolizumab in patients with triple-negative breast cancer.NCT03310957·Birmingham, Alabama and 49 others

TerminatedAkt Inhibitor MK-2206 and Anastrozole With or Without Goserelin Acetate in Treating Patients With Stage II-III Breast CancerThis phase II trial studies how well Akt inhibitor MK-2206 (MK-2206) and anastrozole with or without goserelin acetate works in treating patients with stage II-III breast cancer.NCT01776008·Scottsdale, Arizona and 7 others

PreviousPage 18 of 45Next

Other Conditions in Maryland

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma